ADMA Biologics, Inc. (ADMA)
NASDAQ: ADMA · Real-Time Price · USD
9.56
-0.02 (-0.21%)
Sep 4, 2026, 2:05 PM EDT - Market open
ADMA Biologics Market Cap
ADMA Biologics has a market cap or net worth of $2.14 billion as of September 4, 2026. Its market cap has decreased by -46.90% in one year.
Market Cap
2.14B
Enterprise Value
2.21B
1-Year Change
-46.90%
Ranking
Category
Stock Price
$9.56
ChartMarket Cap Chart
Since October 17, 2013, ADMA Biologics's market cap has increased from $50.20M to $2.14B, an increase of 4,165.52%. That is a compound annual growth rate of 33.80%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 2.14B | -50.67% |
| Dec 31, 2025 | 4.34B | 7.08% |
| Dec 31, 2024 | 4.05B | 296.92% |
| Dec 29, 2023 | 1.02B | 33.78% |
| Dec 30, 2022 | 763.50M | 176.53% |
| Dec 31, 2021 | 276.10M | 49.73% |
| Dec 31, 2020 | 184.40M | -22.29% |
| Dec 31, 2019 | 237.30M | 114.17% |
| Dec 31, 2018 | 110.80M | -12.41% |
| Dec 29, 2017 | 126.50M | 91.67% |
| Dec 30, 2016 | 66.00M | -23.70% |
| Dec 31, 2015 | 86.50M | -16.67% |
| Dec 31, 2014 | 103.80M | 44.37% |
| Dec 31, 2013 | 71.90M | 43.23% |
| Oct 17, 2013 | 50.20M | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kodiak Sciences | 2.28B |
| Palvella Therapeutics | 2.24B |
| Mesoblast | 2.22B |
| UroGen Pharma | 2.19B |
| Zenas BioPharma | 2.15B |
| Aurinia Pharmaceuticals | 2.14B |
| Zymeworks | 2.12B |
| Generate Biomedicines | 2.10B |